Arbutus Biopharma (ABUS) Earnings
|
Expand Research on ABUS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +12.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26  |
Q425 | N/A | -$0.03 | N/A | N/A | $776.33K | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$0.03 | N/A | N/A | $776.33K | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | N/A | -$0.03 | N/A | N/A | $776.33K | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.03 | N/A | N/A | $776.33K | N/A | N/A | N/A | ||
| 11/13/25 | Q325 | -$0.04 | -$0.03 | -$0.01 | $530K | $1.39M | N/A |  | | Details | |
| 11/12/25 |
Q325 | N/A | -$0.03 | N/A | N/A | $1.39M | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | -$0.03 | N/A | N/A | $1.39M | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.03 | N/A | N/A | $1.39M | N/A | N/A | N/A |
